|
1.
|
Wong F and Choi T: Primary liver cancer.
Asian experience. Surgery of Liver and Biliary Tract. Blumgart LH:
Churchill-Livingstone; London: pp. 1135–1151. 1988
|
|
2.
|
The Research Group for Population-based
Cancer Resistration in Japan: Cancer incidence and incidence rates
in Japan in 1995: estimates based on data from nine
population-based cancer registries. Jpn J Clin Oncol. 30:318–321.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Tanaka H and Tsukuma H: Hepatitis C virus.
Cancer Surveys: Infections and Human Cancer. Newton R, Beral V,
Weiss RA and Tooze J: Cold Spring Harbor Laboratory; New York: pp.
213–235. 1999
|
|
4.
|
Di Bisceglie AM, Goodman ZD, Ishak KG,
Hoofnagle JH, Melpolder JJ and Alter HJ: Long-term clinical and
histopathological follow-up of chronic posttransfusion hepatitis.
Hepatology. 14:969–974. 1991.PubMed/NCBI
|
|
5.
|
Kiyosawa K, Sodeyama T, Tanaka E, et al:
Interrelationship of blood transfusion, non-A, non-B hepatitis and
hepatocellular carcinoma: analysis by detection of antibody to
hepatitis C virus. Hepatology. 12:671–675. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Marrero JA, Fontana RJ, Su GL, Conjeevaram
HS, Emick DM and Lok AS: NAFLD may be a common underlying liver
disease in patients with hepatocellular carcinoma in the United
States. Hepatology. 36:1349–1354. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Davila JA, Morgan RO, Shaib Y, McGlynn KA
and El-Serag HB: Hepatitis C infection and the increasing incidence
of hepatocellular carcinoma: a population-based study.
Gastroenterology. 127:1372–1380. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Seeff LB and Hoofnagle JH: Epidemiology of
hepatocellular carcinoma in areas of low hepatitis B and hepatitis
C endemicity. Oncogene. 25:3771–3777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Hatanaka K, Kudo M, Fukunaga T, et al:
Clinical characteristics of NonBNonC-HCC: Comparison with HBV and
HCV related HCC. Intervirology. 50:24–31. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Davila JA, Morgan RO, Shaib Y, McGlynn KA
and El-Serag HB: Diabetes increases the risk of hepatocellular
carcinoma in the United States: a population based case control
study. Gut. 54:533–539. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Gerber M, Thung S and Popper H: Pathology
of alcoholic liver injury. Update 1981 and problems. New Trends in
Hepatology. Oda T and Okuda K: Medical Tokyo Co Ltd; Tokyo: pp.
8–12. 1986
|
|
12.
|
Haddow JE, Palomaki GE, McClain M and
Craig W: Hereditary haemochromatosis and hepatocellular carcinoma
in males: a strategy for estimating the potential for primary
prevention. J Med Screen. 10:11–13. 2003. View Article : Google Scholar
|
|
13.
|
Moucari R, Rautou PE, Cazals-Hatem D, et
al: Hepatocellular carcinoma in Budd-Chiari syndrome:
characteristics and risk factors. Gut. 57:828–835. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Hashimoto E, Yatsuji S, Kaneda H, et al:
The characteristics and natural history of Japanese patients with
nonalcoholic fatty liver disease. Hepatol Res. 33:72–76. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Sasaki Y: Does oxidative stress
participate in the development of hepatocellular carcinoma? J
Gastroenterol. 41:1135–1148. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Shibutani S, Takeshita M and Grollman AP:
Insertion of specific bases during DNA synthesis past the
oxidation-damaged base 8-oxodG. Nature. 349:431–434. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Hussain SP and Harris CC: Molecular
epidemiology of human cancer: contribution of mutation spectra
studies of tumor suppressor genes. Cancer Res. 58:4023–4037.
1998.
|
|
18.
|
Zhang H, Xu Y, Kamendulis LM and Klaunig
JE: Morphological transformation by 8-hydroxy-2′-deoxyguanosine in
Syrian hamster embryo (SHE) cells. Toxicol Sci. 56:303–312.
2000.
|
|
19.
|
Nakae D, Kobayashi Y, Akai H, et al:
Involvement of 8-hydroxyguanine formation in the initiation of rat
liver carcinogenesis by low dose levels of N-nitrosodiethylamine.
Cancer Res. 57:1281–1287. 1997.PubMed/NCBI
|
|
20.
|
Kitada T, Seki S, Iwai S, Yamada T,
Sakaguchi H and Wakasa K: In situ detection of oxidative DNA
damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. J
Hepatol. 35:613–618. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Ichiba M, Maeta Y, Mukoyama T, et al:
Expression of 8-hydroxy-2′-deoxyguanosine in chronic liver disease
and hepatocellular carcinoma. Liver Int. 23:338–345. 2003.
|
|
22.
|
Bartsch H and Nair J: Oxidative stress and
lipid peroxidation-derived DNA-lesions in inflammation driven
carcinogenesis. Cancer Detect Prev. 28:385–391. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Hu W, Feng Z, Eveleigh J, et al: The major
lipid peroxidation product, trans-4-hydroxy-2-nonenal,
preferentially forms DNA adducts at codon 249 of human p53 gene, a
unique mutational hotspot in hepatocellular carcinoma.
Carcinogenesis. 23:1781–1789. 2002. View Article : Google Scholar
|
|
24.
|
Liu R, Buettner GR and Oberley LW: Oxygen
free radicals mediate the induction of manganese superoxide
dismutase gene expression by TNF-alpha. Free Radic Biol Med.
28:1197–1205. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Qadri I, Iwahashi M, Capasso JM, et al:
Induced oxidative stress and activated expression of manganese
superoxide dismutase during hepatitis C virus replication: role of
JNK, p38 MAPK and AP-1. Biochem J. 378:919–928. 2004. View Article : Google Scholar
|
|
26.
|
Pugh RN, Murray-Lyon IM, Dawson JL,
Pietroni MC and Williams R: Transection of the oesophagus for
bleeding oesophageal varices. Br J Surg. 60:646–649. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Nanashima A, Sumida Y, Morino S, et al:
The Japanese integrated staging score using liver damage grade for
hepatocellular carcinoma in patients after hepatectomy. Eur J Surg
Oncol. 30:765–770. 2004. View Article : Google Scholar
|
|
28.
|
Liver Cancer Study Group of Japan: General
Rules for the Clinical and Pathological Study of Primary Liver
Cancer. 2nd English edition. Kanehara; Tokyo: 2003
|
|
29.
|
Sobin L and Witteking C: International
Union Against Cancer Union TMN Classification of malignant tumors.
5th edition. John Wiley & Sons, Inc; New York: 1997
|
|
30.
|
Desmet VJ, Gerber M, Hoofnagle JH, Manns M
and Scheuer PJ: Classification of chronic hepatitis: diagnosis,
grading and staging. Hepatology. 19:1513–1520. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Brunt EM, Janney CG, Di Bisceglie AM,
Neuschwander-Tetri BA and Bacon BR: Nonalcoholic steatohepatitis: a
proposal for grading and staging the histological lesions. Am J
Gastroenterol. 94:2467–2474. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Deugnier YM, Loreal O, Turlin B, et al:
Liver pathology in genetic hemochromatosis: a review of 135
homozygous cases and their bioclinical correlations.
Gastroenterology. 102:2050–2059. 1992.PubMed/NCBI
|
|
33.
|
Chuma M, Hige S, Nakanishi M, et al:
8-Hydroxy-2′-deoxyguanosine is a risk factor for development of
hepatocellular carcinoma in patients with chronic hepatitis C virus
infection. J Gastroenterol Hepatol. 23:1431–1436. 2008.
|
|
34.
|
Tanaka H, Fujita N, Sugimoto R, et al:
Hepatic oxidative DNA damage is associated with increased risk for
hepatocellular carcinoma in chronic hepatitis C. Br J Cancer.
98:580–586. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Matsumoto K, Satoh Y, Sugo H, et al:
Immunohistochemical study of the relationship between
8-hydroxy-2′-deoxyguanosine levels in noncancerous region and
postoperative recurrence of hepatocellular carcinoma in remnant
liver. Hepatol Res. 25:435–441. 2003.
|
|
36.
|
Maki A, Kono H, Gupta M, et al: Predictive
power of biomarkers of oxidative stress and inflammation in
patients with hepatitis C virus-associated hepatocellular
carcinoma. Ann Surg Oncol. 14:1182–1190. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Paradis V, Kollinger M, Fabre M, Holstege
A, Poynard T and Bedossa P: In situ detection of lipid peroxidation
by-products in chronic liver diseases. Hepatology. 26:135–142.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Kageyama F, Kobayashi Y, Kawasaki T,
Toyokuni S, Uchida K and Nakamura H: Successful interferon therapy
reverses enhanced hepatic iron accumulation and lipid peroxidation
in chronic hepatitis C. Am J Gastroenterol. 95:1041–1050. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Coleman JD, Prabhu KS, Thompson JT, et al:
The oxidative stress mediator 4-hydroxynonenal is an intracellular
agonist of the nuclear receptor peroxisome proliferator-activated
receptor-beta/delta (PPARbeta/delta). Free Radic Biol Med.
42:1155–1164. 2007. View Article : Google Scholar
|
|
40.
|
Boya P, de la Pena A, Beloqui O, et al:
Antioxidant status and glutathione metabolism in peripheral blood
mononuclear cells from patients with chronic hepatitis C. J
Hepatol. 31:808–814. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Kawaguchi T, Suzuki K, Matsuda Y, et al:
Serum-manganesesuperoxide dismutase: normal values and increased
levels in patients with acute myocardial infarction and several
malignant diseases determined by an enzyme-linked immunosorbent
assay using a monoclonal antibody. J Immunol Methods. 127:249–254.
1990. View Article : Google Scholar
|
|
42.
|
Aida Y, Maeyama S, Takakuwa T, et al:
Immunohistochemical expression of manganese superoxide dismutase in
hepatocellular carcinoma, using a specific monoclonal antibody. J
Gastroenterol. 29:443–449. 1994. View Article : Google Scholar
|
|
43.
|
Clemente C, Elba S, Buongiorno G, et al:
Manganese superoxide dismutase activity and incidence of
hepatocellular carcinoma in patients with Child-Pugh class A liver
cirrhosis: a 7-year follow-up study. Liver Int. 27:791–797.
2007.
|
|
44.
|
Sutton A, Nahon P, Pessayre D, et al:
Genetic polymorphisms in antioxidant enzymes modulate hepatic iron
accumulation and hepatocellular carcinoma development in patients
with alcohol-induced cirrhosis. Cancer Res. 66:2844–2852. 2006.
View Article : Google Scholar
|
|
45.
|
Ezzikouri S, El Feydi AE, Chafik A, et al:
Genetic polymorphism in the manganese superoxide dismutase gene is
associated with an increased risk for hepatocellular carcinoma in
HCV-infected Moroccan patients. Mutat Res. 649:1–6. 2008.
View Article : Google Scholar
|
|
46.
|
Seki S, Kitada T, Yamada T, Sakaguchi H,
Nakatani K and Wakasa K: In situ detection of lipid peroxidation
and oxidative DNA damage in non-alcoholic fatty liver diseases. J
Hepatol. 37:56–62. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Toyoda H, Kumada T, Kiriyama S, et al:
Characteristics and prognosis of patients in Japan with viral
marker-negative hepatocellular carcinoma. J Gastroenterol Hepatol.
23:459–466. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Higashi Y, Tada S, Miyase S, et al:
Correlation of clinical characteristics with detection of hepatitis
B virus X gene in liver tissue in HBsAg-negative, and HCV-negative
hepatocellular carcinoma patients. Liver. 22:374–379. 2002.
View Article : Google Scholar
|
|
49.
|
Yokoi Y, Suzuki S, Baba S, Inaba K, Konno
H and Nakamura S: Clinicopathological features of hepatocellular
carcinomas (HCCs) arising in patients without chronic viral
infection or alcohol abuse: a retrospective study of patients
undergoing hepatic resection. J Gastroenterol. 40:274–282. 2005.
View Article : Google Scholar
|
|
50.
|
Watabe H, Shiratori Y, Tateishi R, et al:
Clinical features of patients with HCC who are negative for both
HBV and HCV markers. Hepatogastroenterology. 50:2157–2160.
2003.PubMed/NCBI
|
